)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Park Ha Biological Technology
Park Ha Biological Technology (BYAH) investor relations material
Park Ha Biological Technology Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary4 Jun, 2026
Management team and governance
Principal executive offices are located in Wuxi, Jiangsu Province, China, with a U.S. agent for service in New York.
The CEO is Xiaoqiu Zhang, who also serves as a director; other key officers include the CFO (Xiaoyan Zhu), CTO (Xinyu Li), and additional directors.
Directors and officers are indemnified against losses except in cases of dishonesty, fraud, or willful neglect.
Offering details and pricing
The registration statement is for the issuance of securities from time to time after the effective date, under a shelf registration (Form F-3).
The offering may include senior and subordinated debt securities, warrants, rights, share purchase contracts, and units, with terms to be set by board resolution or supplemental indenture.
Securities may be issued in one or more series, with an unlimited aggregate principal amount authorized.
Underwriters and syndicate
Any underwriting agreement will provide for indemnification of the company and its officers and directors in certain cases.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Park Ha Biological Technology
- Offering up to $300M in securities, the company targets skincare growth in China amid high regulatory risk.BYAH
Registration filing - Offering up to $300 million in securities, the company targets growth in China's skincare market amid regulatory risks.BYAHRegistration filing
- FY2025 saw revenue growth but a large net loss due to share-based compensation, with strong gross margins.BYAHQ4 2025
- IPO raised $4.8M, shares listed as "PHH" on Nasdaq, with strong governance and incentive plans.BYAHRegistration Filing
- FY2024 revenue declined 3% to $2.38M, net income dropped 44%, and gross margin rose to 92%.BYAHQ4 2024
- Franchise skincare firm seeks $2.5M for store expansion, with high China regulatory and market risks.BYAHRegistration Filing
- High-margin skincare business with broad China presence and ongoing R&D-driven growth.BYAHCorporate Presentation
- Franchise skincare firm seeks $3.5M via Nasdaq share/warrant offering amid regulatory and financial risks.BYAHRegistration Filing
- IPO targets $7.2M for China skincare expansion; CEO retains control; FY2023 revenue up, H1 2024 down.BYAHRegistration Filing
Next Park Ha Biological Technology earnings date
Q3 202620 Nov, 2026
Park Ha Biological Technology
Next Park Ha Biological Technology earnings date
Q3 202620 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Park Ha Biological Technology Co Ltd is engaged in the research, development, production, and sale of biotechnology products. The company focuses on the application of biological fermentation and enzyme engineering technologies across various sectors, including agriculture, food processing, and environmental protection. Its product offerings include microbial agents, bio-fertilizers, and enzymatic preparations. The company is headquartered in Beijing, China, and its shares are listed on the SZSE.